LPN exams pharmacology practice questions set 10

Correct answer:

The correct answer is B: Beta-adrenergic receptors. Albuterol is a beta-2 adrenergic agonist that works by binding to beta-2 adrenergic receptors in the airway smooth muscle, leading to bronchodilation. This mechanism helps in treating conditions like asthma and COPD. Choice A (Alpha-adrenergic receptors) is incorrect because albuterol specifically targets beta-adrenergic receptors, not alpha-adrenergic receptors. Choice C (Cholinergic receptors) is incorrect because albuterol does not directly interact with cholinergic receptors. Choice D (Dopaminergic receptors) is incorrect as albuterol does not have a significant affinity for dopaminergic receptors. In conclusion, the correct answer is B because albuterol's mechanism of action involves activating beta-adrenergic receptors to produce bronchodilation.

Correct answer:

The correct answer is D: You can take acetaminophen, also known as Tylenol, for pain, but no more than 3000 mg per day. Rationale: 1. Acetaminophen is a suitable option for mild to moderate pain relief and is less likely to cause drowsiness compared to opioids. 2. The recommended maximum daily dose of acetaminophen is 3000 mg to avoid potential liver damage. 3. Advising the patient to take acetaminophen up to 3000 mg per day balances pain management with patient safety. 4. Option C's limit of 1000 mg per day may not provide sufficient pain relief for the patient's condition. 5. Option A is too vague and does not address the patient's pain management needs effectively. 6. Option B suggests opioid use without considering the patient's preference to avoid strong medications that may impair his ability to drive.

Correct answer:

The correct answer is B: Droperidol. Droperidol is commonly used in combination with fentanyl in neuroleptanalgesia due to its potent antiemetic and sedative properties. It helps enhance the analgesic effects of fentanyl and provides better sedation during procedures. Rationale: 1. Haloperidol (A) is not typically used in neuroleptanalgesia as it lacks the same synergistic effects with opioids as droperidol. 2. Chlorpromazine (C) is not commonly used in neuroleptanalgesia and is more often used in the treatment of psychotic disorders. 3. Clozapine (D) is an atypical antipsychotic and is not part of the standard neuroleptanalgesia regimen. In summary, droperidol is the preferred antipsychotic agent for use in combination with fentanyl in neuroleptanalgesia due to its specific pharmacological properties that

Correct answer:

The correct answer is A: Advise the patient to be patient, since these side effects are only temporary. Rationale: 1. The side effects described (shuffling gait, masklike face, drooling) are indicative of extrapyramidal symptoms caused by chlorpromazine. 2. These side effects are common with typical antipsychotic medications like chlorpromazine. 3. Advising the patient to be patient is inappropriate as these symptoms may not resolve on their own. 4. Seeking a physician order for an antiparkinsonian medication (choice B) or administering trihexyphenidyl (choice D) would be appropriate interventions to manage the extrapyramidal symptoms. 5. Suggesting carrying a towel and initiating fall precautions (choice C) is important for managing the drooling and potential fall risk associated with the gait disturbances.

Correct answer:

The most likely predisposing factor contributing to the proximal end of the femur fracture in a 62-year-old woman is osteoporosis resulting from declining hormone levels. Osteoporosis weakens the bones, making them more susceptible to fractures, especially in older adults, particularly women. In this case, the fracture can be attributed to the bone density loss associated with osteoporosis, which is a common concern in postmenopausal women. Choices A, B, and D are less likely to have directly contributed to the femur fracture in this scenario. Failing eyesight may increase the risk of falls but does not directly weaken the bones. Renal osteodystrophy affects bone health but is less common in this age group. Cerebral vessel changes causing transient ischemic attacks are related to vascular issues, not bone strength.

Correct answer:

The correct answer is C: Inositol triphosphate. Loratadine is an antihistamine used to treat allergic conditions like urticaria by blocking histamine receptors. Histamine binds to H1 receptors on cells, leading to the activation of phospholipase C, which cleaves phosphatidylinositol 4,5-bisphosphate into inositol triphosphate (IP3) and diacylglycerol. IP3 triggers the release of intracellular calcium stores, leading to various cellular responses including allergic reactions. By blocking histamine receptors, loratadine reduces the synthesis of IP3, hence mediating its therapeutic effect. Choice A (cAMP) is incorrect because loratadine does not directly affect the cAMP pathway. Choice B (cGMP) is incorrect as it is not involved in the mechanism of action of loratadine. Choice D (Cyclooxygenase-1) is incorrect as

Correct answer:

Step-by-step rationale for why Answer A is correct: 1. Desensitization, internalization, and downregulation of receptors can lead to tolerance by reducing the responsiveness of receptors to a drug. 2. Higher drug doses are needed to achieve the same effect due to decreased receptor sensitivity. 3. Enhanced drug elimination can reduce drug concentrations, requiring higher doses to achieve the desired response. 4. Therefore, the statement accurately describes the mechanisms of tolerance development. Summary: Choice A is correct because it accurately explains how desensitization, internalization, downregulation of receptors, and enhanced drug elimination can contribute to the development of tolerance. Choices B, C, and D are incorrect as they do not provide a comprehensive explanation of tolerance mechanisms.

Correct answer:

The correct answer is that distribution depends on the unbound drug concentration gradient between blood and tissue (C). Only free (unbound) drug can cross membranes into tissues, driven by the concentration gradient, as per Fick's law of diffusion. Option A is false; blood flow (e.g., high to brain, low to fat) significantly affects distribution, as seen with anesthetics. Option B is incorrect; tissue solubility (lipid vs. aqueous) determines partitioning, like thiopental in fat. Option D is wrong; strong plasma protein binding (e.g., warfarin) reduces free drug, limiting distribution. Option E (original) about half-life is unrelated. This gradient-driven process explains rapid onset in highly perfused organs and prolonged effects in poorly perfused ones, critical for therapeutic targeting and avoiding toxicity.

Correct answer:

The correct answer is B because it is usually recommended that children younger than 2 years old and adults 65 years or older get vaccinated against pneumococcal disease. This is because these age groups are more susceptible to severe complications from the infection. While the vaccine may be recommended for certain individuals with specific medical conditions at any age, the primary target groups are as mentioned in option B. Option A is incorrect as the pneumococcal vaccine is not given annually like the flu vaccine. Option C is incorrect because the vaccine is not primarily for travelers but for certain age groups and individuals with medical conditions at risk. Option D is incorrect as the vaccine's duration of protection can vary, and it is not guaranteed to prevent pneumococcal pneumonia for up to 5 years.

Correct answer:

The correct answer is B because when the peak level for a drug is above the minimum toxic concentration, it indicates that the concentration will produce an adverse response. This is because high drug levels can lead to toxicity and harmful effects on the body. The other choices are incorrect because: A: Concentration will produce therapeutic effects - This is incorrect because being above the minimum toxic concentration means the drug level is too high for therapeutic effects. C: Time between doses must be shortened - This is incorrect as adjusting the time between doses does not address the issue of drug toxicity. D: Duration of action of the drug is too long - This is incorrect because the duration of action does not directly relate to drug toxicity; it is the concentration level that determines toxicity.